Dr Harding was awarded his PhD in Molecular Biology and Nanotechnology at the University of the Sunshine Coast (USC) in 2020. Bradley applies his experience in molecular biology research at BioCifer by overseeing the development and operation of BioCifer’s manufacturing and research infrastructure, as well as contributing to the development and manufacturing of BioCifer’s diagnostic products.

Bradley has a strong focus on exploring the current capabilities of state-of-the-art biosensor technology, to determine how new technologies can be best adopted and built upon for faster, more accurate, and more affordable diagnostics. With a background in synthetic biology and nanobiotechnology, Bradley has previously applied circuit logic to biocomputing systems, providing a greater depth of control for smart biosensors.